Page 145 - The clinical aspects and management of chronic migraine Judith Anne Pijpers

21. Buettner C, Melo-Carrillo A, Burstein R. Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug Trial. Headache J Head Face Pain. 2017;57(3):478-486. doi:10.1111/head.13031
22. Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AMJM. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol. 2015;14(1):65- 80. doi:10.1016/S1474-4422(14)70220-0
23. Schulte LH, May A. The migraine generator revisited: Continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(7):1987-1993. doi:10.1093/brain/ aww097
24. Fuchs E, Flügge G. Adult neuroplasticity: More than 40 years of research. Neural Plast. 2014;2014. doi:10.1155/2014/541870
25. Scher AI, Buse DC, Fanning KM, et al. Comorbid pain and migraine chronicity The Chronic Migraine Epidemiology and Outcomes Study. 2017;0.
26. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63(2):148-158. doi:10.1002/ana.21211
27. Arendt-Nielsen L, Morlion B, Perrot S, et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain. 2018;22(2):216-241. doi:10.1002/ejp.1140
28. Colvin LA, Bull F, Hales TG. Perioperative opioid analgesia—when is enough too much? A review of opioid-induced tolerance and hyperalgesia. Lancet. 2019;393(10180):1558-1568. doi:10.1016/ S0140-6736(19)30430-1
29. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010;9(4):391-401. doi:10.1016/S1474-4422(10)70008-9
30. Diener H-C, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019;4422(19):1-12. doi:10.1016/S1474-4422(19)30146-2
31. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003;43(3):179-190. doi:10.1046/j.1526- 4610.2003.03041.x
32. De Felice M, Ossipov MH, Wang R, et al. Triptan-induced latent sensitization a possible basis for medication overuse headache. Ann Neurol. 2010;67(3):325-337. doi:10.1002/ana.21897
33. Louter M, Wardenaar K, Veen G, et al. Allodynia is associated with a higher prevalence of depression in migraine patients. Cephalalgia. 2014;34(14):1187-1192. doi:10.1177/0333102414532554
34. Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine Progression: A Systematic Review. Headache J Head Face Pain. 2019;59(3):306-338. doi:10.1111/head.13459
35. Xie JY, De Felice M, Kopruszinski CM, et al. Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention. Cephalalgia. 2017;37(8):780-794. doi:10.1177/0333102417702120
36. Nation KM, De Felice M, Hernandez PI, et al. Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain. Pain. 2018;159(5):919-928. doi:10.1097/j.pain.0000000000001167
37. Crowley NA, Kash TL. Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment. Prog Neuro-Psychopharmacology Biol Psychiatry. 2015;62:51-60. doi:10.1016/j. pnpbp.2015.01.001
38. Brines M, Swartjes M, Tannemaat MR, et al. Corneal nerve quantification predicts the severity of symptoms in sarcoidosis patients with painful neuropathy. Technology. 2013;01(01):20-26. doi:10.1142/S2339547813500039
39. Petropoulos IN, Alam U, Fadavi H, et al. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care. 2013;36(11):3646-3651. doi:10.2337/dc13-0193
40. Kinard KI, Smith AG, Singleton JR, et al. Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eye. Headache. 2015;55(4):543-549. doi:10.1111/head.12547
41. Tavakoli M, Mitu-Pretorian M, Petropoulos IN, et al. Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes. 2013;62(1):254-260. doi:10.2337/db12-0574
7
Summary and general discussion
143